GLWL Research, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://glwlresearch.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Study of GLWL-01 in Patients With Prader-Willi Syndrome
- First Posted Date
- 2017-09-07
- Last Posted Date
- 2020-03-27
- Lead Sponsor
- GLWL Research Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT03274856
- Locations
- 🇺🇸
Rady Children's Hospital San Diego, San Diego, California, United States
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸University Hospitals, Cleveland Medical Center, Cleveland, Ohio, United States
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01
Phase 1
Terminated
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: GLWL-01, Part CDrug: GLWL-01, Part ADrug: Placebo, Part ADrug: GLWL-01, Part BDrug: Placebo, Part BDrug: Placebo, Part C
- First Posted Date
- 2015-03-03
- Last Posted Date
- 2019-03-21
- Lead Sponsor
- GLWL Research Inc.
- Target Recruit Count
- 74
- Registration Number
- NCT02377362
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
🇺🇸Profil Institute for Clinical Research, Inc., Chula Vista, California, United States
🇺🇸Clinical Pharmacology of Miami, Inc., Miami, Florida, United States
News
No news found